IMA
ImageneBioCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
IMA vs peer average
58/100
IMA vs. peer average (C vs. C)
Grade spread
A 1 · B 3 · D 2 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ATYR is the first available peer comparator.
Another loose small-cap biotech comp from the packet; supports a sector frame where cash runway and clinical milestones matter more than current revenue, but indication overlap is limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMA
ImageneBio
ATYR
aTyr
Grade
C
F
Momentum
58
8
Value
57
58
Sentiment
43
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs ATYR
IMA / ATYR
Grade Position
In line
IMA vs. peer average (C vs. C)
58/100
Momentum
58
IMAValue
57
ATYRSentiment
43
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMA
ATYR is the first peer returned for this comparison set.